FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group pur.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC Launches Inquiry Into Prescription Drug Middlemen Industry
WEBJun 7, 2022 · The Federal Trade Commission announced today that it will launch an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information and records regarding their business practices.
High insulin prices spur a federal lawsuit against three pharmacy ...
WEB1 day ago · Pharmacy benefit managers, or PBMs, run prescription drug coverage for insurers, large employers and other clients. They set up formularies, or lists of covered drugs, and negotiate rebates off the drug prices. The FTC said the rebating practices of the three companies have led to artificially inflated list prices for people.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug...
FTC sues CVS, Cigna, UnitedHealth PBMs over insulin prices - STAT
WEB1 day ago · The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that...
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
WEBJul 9, 2024 · Investigation finds firms, which are supposed to control spending, have overcharged for cancer drugs and taken other steps raising costs. The Federal Trade Commission launched its...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB1 day ago · Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while making it harder for patients to obtain...
FTC Sues Pharmacy Benefit Managers for Inflating Insulin Prices
WEB1 day ago · Today, the Federal Trade Commission (FTC) announced that the organization filed legal action against the country’s three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts and OptumRx—for engaging in anti-competitive and unfair practices that inflated the price of insulin drugs, blocked patients’ access to ...
Skip to content